COPD Trial, Recruiting NCT06392776 Sponsor: Ottawa Hospital Research Institute Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06392776
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years old or older
  • People who are currently experiencing breathing or respiratory symptoms
  • People who complete a questionnaire called the UCAP-Q and receive a score showing at least a 6% chance of having asthma or COPD
  • People who have signed a written consent form agreeing to take part in the trial, following local rules and regulations
  • People who are able to complete a breathing test (called spirometry) both before and after taking a medication that opens the airways
  • For the randomised controlled part of the trial: people whose spirometry results show an undiagnosed airflow problem, which may indicate asthma or COPD

Who may not be able to join:

  • People who have already been diagnosed with asthma, COPD, lung cancer, bronchiectasis, interstitial lung disease, cystic fibrosis, or another significant lung condition
  • People who are currently under the care of a lung specialist (respirologist)
  • People who are currently using inhaled corticosteroid or long-acting bronchodilator medications
  • People who have had a heart attack, stroke, aortic or brain aneurysm, detached retina, or eye surgery within the past 3 months, as the breathing test may not be safe in these cases
  • People who are in the third trimester of pregnancy
  • People who are currently taking part in another interventional clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shawn Aaron, MD, Ottawa Hospital Research Institute

Phone: 6137378259

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ottawa Hospital Research Institute
Registry
ClinicalTrials.gov
Start date
16 July 2024
Est. completion
1 December 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in disease-specific quality of life quantified using the St. George's Respiratory Questionnaire (SGRQ).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov